BusinessNumber of People with Epilepsy in the United States at All-time High, CDC ReportsBy Nasdaq OMXAug 10, 2017, 5:00 PM UTC
BusinessAdamas to Announce Second Quarter 2017 Financial Results and Host Conference Call on August 8, 2017By Nasdaq OMXAug 1, 2017, 6:33 PM UTC
BusinessEarth Science Tech, Inc. Finalizes New KannaBidioiD Product Labels & Updates ShareholdersBy Nasdaq OMXJul 27, 2017, 12:25 PM UTC
BusinessShopko Named as Kick-Off Partner for Lemonade for Livy to Support Local Epilepsy FoundationsBy Nasdaq OMXJun 12, 2017, 2:00 PM UTC
BusinessEpilepsy Foundation Awards $200,000 at ‘Shark Tank’ Competition for Innovative Products to Help People Living with SeizuresBy Nasdaq OMXMay 31, 2017, 3:10 PM UTC
BusinessAdamas Presents Positive Phase 1a Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in EpilepsyBy Nasdaq OMXMay 22, 2017, 12:36 PM UTC
BusinessAdamas Presents Positive Phase 1a Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in EpilepsyBy Nasdaq OMXMay 22, 2017, 12:36 PM UTC
BusinessAdamas Presents Positive Phase 1a Data of ADS-4101 (lacosamide) for the Treatment of Partial Onset Seizures in EpilepsyBy Nasdaq OMXMay 22, 2017, 12:36 PM UTC
